Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 327

Selected Filters:
14 July 2026

LEN Learning Clinic 3: Clinical Case Reviews to Optimize LEN Provision

The successful rollout of lenacapavir extends beyond injection administration and requires providers to effectively prepare, counsel, and support clients throughout their prevention journey. A dedicated learning clinic on injection site reactions, post-injection care, and counselling will build provider confidence in anticipating and managing expected reactions, delivering consistent counselling messages, and addressing client concerns. Strengthening these…

Service Delivery

Event
10 July 2026

Long-Acting Injectable Cabotegravir Use and Persistence Over Two Years

This article from JAMA Network Open explores levels of cabotegravir for PrEP uptake and persistence in the US since approval by the US Food and Drug Administration in December 2021.

Research, Service Delivery

External Link
18 June 2026

Report on Access to PrEP in Europe, 2026

This 2026 report from AIDS Action Europe (AAE) maps PrEP access across the European Union and European Economic Area and recent developments. It draws on information from AAE member organisations, covering the availability, accessibility, affordability and acceptability of PrEP.

Monitoring & Evaluation, Research, Service Delivery

External Link
18 June 2026

UNAIDS Global AIDS Brief: United to End AIDS

This report from UNAIDS outlines how external funding cuts, a strong push back on human rights, and under investment and under prioritization of HIV prevention and community services are threatening to reverse years of gains in the AIDS response.

Monitoring & Evaluation, Research, Service Delivery

External Link
5 June 2026

LEN Rollout Resources and Tools

The resources listed in this document, alongside insights drawn from the report Getting PrEP Rollout Right This Time, can support countries in the early stages of LEN planning. These tools are being disseminated as part of a coordinated effort between AVAC, CHAI, CIFF, the Global Fund, PEPFAR, PSI, Unitaid, Wits RHI, and WHO under the…

Community/Advocacy, Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery, Supply Chain Management

Document
20 May 2026

LEN Learning Clinic 2: Clinical Considerations for the Implementation of LEN

This learning clinic brings together governments, implementing partners, health care providers, and technical assistance teams to share and discuss clinical insights and considerations for the delivery of LEN- with a focus on practical skills focussed on injection preparation and technique, managing side effects, choice counselling, and delivery to pregnant and lactating people. Who should attend:…

Service Delivery

Event
19 May 2026

Global PrEP Tracker

Last update: April 2026 Visit data.prepwatch.org for a dynamic map-based tool to explore trends in PrEP use globally, including by country, product, and time period. Comprehensive datasets are available to download by clicking “download data” in the upper righthand corner. For any questions, contact [email protected]. Introduction to the Global PrEP Tracker

Monitoring & Evaluation, Service Delivery

External Link
14 May 2026

Advancing Equitable Access to Lenacapavir for PrEP (Global Focus)

The recent significant changes to global health funding have severely impacted HIV prevention services for those who need them most, in particular key populations (KPs). Already, some countries are seeing concerning trends in data suggesting a resurgence in new infections. At the same time, powerful new HIV prevention options are now a reality, though their…

Community/Advocacy, Demand Creation/Marketing, Service Delivery

Event
14 May 2026

Advancing Equitable Access to Lenacapavir for PrEP (Africa Focus)

The recent significant changes to global health funding have severely impacted HIV prevention services for those who need them most, in particular key populations (KPs). Already, some countries are seeing concerning trends in data suggesting a resurgence in new infections. At the same time, powerful new HIV prevention options are now a reality, though their…

Community/Advocacy, Demand Creation/Marketing, Service Delivery

Event
8 May 2026

PrEP Drug Interaction Checker

This website, developed and maintained by the University of Liverpool, provides clear, trustworthy, and up-to-date information about how different PrEP options, including oral PrEP, cabotegravir, lenacapavir, and the dapivirine vaginal ring, can interact with other drugs.

Research, Service Delivery

External Link